Moving at the Speed of Light with Pfizer CEO Albert Bourla

With human lives and global economies in mind, Pfizer CEO Albert Bourla has reallocated many of his company’s resources to focus on coronavirus. In conversation with CNBC’s Meg Tirrell, he discusses vaccine development, timeline, and cost

2356 232